trending Market Intelligence /marketintelligence/en/news-insights/trending/eDQ7vKDY-TJp6OhHH6DuGQ2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Edge Therapeutics transfers listing to Nasdaq Capital Market

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Edge Therapeutics transfers listing to Nasdaq Capital Market

Edge Therapeutics Inc. said it transferred its listing from the Nasdaq Global Select Market to the Nasdaq Capital Market starting March 6.

The Berkeley Heights, N.J.-based biotechnology company's common shares will continue to trade under the symbol EDGE.

The company will also have to regain compliance with Nasdaq's minimum bid price per share requirement, regarding which it received a notice in September 2018.

To regain compliance, the closing bid price per share for the company's common stock should be at least $1.00 for at least 10 consecutive business days.

The company, which has been given additional 180-calendar days to regain compliance, may use a reverse stock split to meet the requirement.